HopeStage
Back to all studies
RecruitingNCT07231497

Modafinil and decision-making tasks in people without psychosis

About this titleRead the official source — NCT07231497
Medication studyAges 18–35United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 35 years.

Listed locations
MinneapolisSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 31, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
103
Sponsor
University of Minnesota
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 35 Years
Official registry ID
NCT07231497
Official title
Show the full official title

Cognitive Strategies in Early Psychosis 1

Recruitment & locations

Currently recruiting

Minneapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Minnesota, a university.

Does this study involve medication?

Yes. The study involves medication, including Modafinil.

Who can participate?

Listed age limits: 18 years to 35 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies